Suzanne Lentzsch

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

Faith E. Davies, Noopur Raje, Teru Hideshima et al. · Blood · 2001 · 901 citations

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

D. Gupta, SP Treon, Yoshihito Shima et al. · Leukemia · 2001 · 554 citations

Marrow Stromal Cells, Cell Therapy, Angiogenesis +8

Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.

Richard LeBlanc, Laurence Catley, Teru Hideshima et al. · PubMed · 2002 · 456 citations

Apoptosis, Immunology, Cell Death +21

Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

Ajai Chari, Attaya Suvannasankha, Joseph W. Fay et al. · Blood · 2017 · 438 citations · Full text

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

Klaus Podar, Yu‐Tzu Tai, Faith E. Davies et al. · Blood · 2001 · 417 citations